Hailey Jones, ATC Physical Medicine & Rehabilitation - Sports Medicine Medicare: Not Enrolled in Medicare Practice Location: 360 S State St Unit C323, Orem, UT 84058 Phone: 870-273-5228 |
Dr. Stuart Wesley King, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 839 E 1200 S, Orem, UT 84097 Phone: 801-224-0891 Fax: 801-224-7100 |
Valton N King, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 839 E 1200 S, Orem, UT 84097 Phone: 801-224-0891 Fax: 801-224-7100 |
News Archive
Type 2 diabetes and obesity are linked to an increased risk of certain cancers. Recently published studies suggested that insulin glargine (a synthetic insulin preparation marketed under the trade name Lantus), may be associated with a higher risk of certain cancers than other insulins or oral glucose lowering medications. However, these studies were unable to control for important factors such as obesity that may have driven the association.
Bowel Cancer UK is pleased to announce that the charity will be part of the lead committee on bowel cancer in the Genomics England genome sequencing project.
In a unique and comprehensive literature review of poisoning deaths involving opioids from 1999 - 2009, the deaths involving methadone were found to be disproportionately high. Methadone represented less than five percent of all opioid prescriptions but is responsible for a third of the deaths. After four years of investigation, the major underlying cause was found to be fundamental misunderstandings about the properties of the medicine - a "knowledge deficit" - especially when converting patients from other opioids.
Zynex, Inc., a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces a record number of orders and billed patients in the three months ended September 30, 2010. The Company also generated record net revenues of $6,657,000 for the three months ended September 30, 2010, which represents a 42% increase over third quarter 2009 net revenue and a 16% increase sequentially over the second quarter of 2010.
A Ludwig Cancer Research study has devised a new type of chimeric antigen-receptor (CAR) T cell-;a family of promising immunotherapies for cancer- that can be switched on and off on demand.
› Verified 4 days ago